NIH supports exploratory and early-stage research to develop selective methods or agents for undruggable targets in intractable human diseases; clinical trials are not allowed.
Funding available for preclinical studies in rare diseases to show effectiveness of proposed treatments for potential further development into clinical trials.
Funding available for research on innovative drug and device treatments for mental disorders, substance use, and alcohol use, promoting collaboration between academia and industry through U01 mechanism.
NIH supports clinical projects that prepare rare disease therapies or diagnostics for trials through biomarkers, outcome measures, or disease characterization; clinical trials are not allowed.
Supporting projects developing innovative technologies for biomedical research, advancing current capabilities for acquiring biomedical knowledge.
NIH supports discovery of in vivo chemical probes for novel brain targets, with applicants expected to have validated starting compounds and bioassays; clinical trials are not allowed.